Plain-English translation of NCT06948773 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot trial is testing the Helix Surgical System, a new surgical device designed to lower eye pressure in people who have both glaucoma and cataracts. The device is used during cataract surgery—the same operation where your cloudy lens is removed and replaced. Researchers want to learn if the treatment is safe and whether it effectively reduces eye pressure without extra procedures.
Many people with glaucoma also develop cataracts and need surgery anyway. This trial explores whether combining both treatments in one operation could help control eye pressure more effectively, potentially reducing the need for daily eye drops or additional procedures.
If you qualify, you would undergo cataract surgery with the Helix Surgical System inserted during the same operation. The study involves 25 participants total, and you would have follow-up visits to check your eye pressure, vision, and any side effects. The trial is currently active but not recruiting new participants at this moment.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
Panama
Sponsor
Sight Sciences, Inc.
Enrollment target
~25 participants
Started
May 2025
Primary completion
September 2026
Age range
45 Years and older
Last updated on clinicaltrials.gov in July 2026.